Montrouge, France, October 22, 2018 — DBV Technologies (Euronext: DB – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for…Original Article
DBV Technologies Announces Submission of Biologics License Application for Viaskin Peanut to the U.S. Food and Drug Administration
